Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1041220119Active, not recruiting
Open-label, single-arm trial of ropivacaine in lung nodule (SPN) and lung neoplasm, sponsored by Kumiai Kosei Hospital. Primary endpoints: pain scale and adverse event. Started Jun 2021; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1041220119.